09.01.05
Calpis Co., Ltd., Tokyo, Japan, has entered into an agreement with Unilever, London, U.K., to license the technologies, patents and trademarks, and to provide the blood pressure regulating ingredient AmealPeptide for blood pressure controlling foods to be manufactured and sold by Unilever in Europe. As a result of this licensing agreement, Unilever has launched a blood pressure controlling dairy beverage incorporating AmealPeptide called Becel/Flora pro.activ in Portugal. With the establishment of functional ingredient sales in Europe, Calpis intends to accelerate the expansion of its ingredients and intellectual property business in the U.S. and other areas, and establish the functional ingredients business a one of its mainstay businesses.